Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex

Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex

Bibliographic Details
Main Authors:	Mikael Alexander Kowal, Arno eHazekamp, Lorenza Serena Colzato, Henk eVan Steenbergen, Bernhard eHommel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-04-01
Series:	Frontiers in Human Neuroscience
Subjects:	Cannabidiol anterior cingulate cortex cognitive processing emotional processing Cannabis sativa
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnhum.2013.00147/full

Similar Items

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
by: Masashi Kitamura, et al.
Published: (2020-09-01)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
by: José A. Crippa, et al.
Published: (2018-09-01)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from <i>Cannabis sativa</i> L
by: Laura Daniela Martinenghi, et al.
Published: (2020-06-01)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
by: Ana Pilar Pérez-Acevedo, et al.
Published: (2020-12-01)

Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug Canabidiol, um componente da Cannabis sativa, como um ansiolítico
by: Alexandre Rafael de Mello Schier, et al.
Published: (2012-06-01)

ESTUDIO DEL CONTENIDO DE CANABINOIDES EN MUESTRAS DE MARIHUANA (Cannabis sativa L.) CULTIVADAS EN VARIAS REGIONES DE COLOMBIA STUDY OF CANNABINOIDS CONTENT IN MARIHUANA SAMPLES (Cannabis sativa L.) CULTIVATED IN SEVERAL REGIONS OF COLOMBIA
by: Néstor M FLORIAN R, et al.
Published: (2009-05-01)

Limited effect of environmental stress on cannabinoid profiles in high‐cannabidiol hemp (Cannabis sativa L.)
by: Jacob A. Toth, et al.
Published: (2021-10-01)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
by: Zackary Montoya, et al.
Published: (2020-09-01)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
by: Patricia Golombek, et al.
Published: (2020-06-01)

El cannabidiol y sus indicaciones en psiquiatría
by: Juan Fernando Muñoz Ramírez
Published: (2021-03-01)

From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
by: Tommaso Cassano, et al.
Published: (2020-03-01)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
by: Davide Fortin, et al.
Published: (2021-10-01)

Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action
by: Marcin Ożarowski, et al.
Published: (2021-04-01)

An orally active Cannabis extract with high content in cannabidiol attenuates chemical induced intestinal inflammation and hypermotility in the mouse
by: Ester Pagano, et al.
Published: (2016-10-01)

An Electrochemical Sensor Based on Amino Magnetic Nanoparticle-Decorated Graphene for Detection of Cannabidiol
by: Yi Zhang, et al.
Published: (2021-08-01)

Cannabidiol Application Increases Cutaneous Aquaporin-3 and Exerts a Skin Moisturizing Effect
by: Nobutomo Ikarashi, et al.
Published: (2021-08-01)

A Balanced Approach for Cannabidiol Use in Chronic Pain
by: Donovan A. Argueta, et al.
Published: (2020-04-01)

Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
by: Karina Genaro, et al.
Published: (2017-06-01)

Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers
by: Marco Antonio Zenone, et al.
Published: (2021-07-01)

Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes
by: Schilling JM, et al.
Published: (2021-05-01)

Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops
by: Eric C. Leas, et al.
Published: (2021-06-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
by: Swapnali Chetia, et al.
Published: (2020-08-01)

Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory
by: J. S. Kaplan, et al.
Published: (2021-08-01)

What are the informational pathways that shape people’s use of cannabidiol for medical purposes?
by: Marco A. Zenone, et al.
Published: (2021-05-01)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
by: Francesco Paolo Busardò, et al.
Published: (2021-01-01)

Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress
by: Veronica Cocetta, et al.
Published: (2021-04-01)

(‒)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research
by: Marialuisa Formato, et al.
Published: (2020-06-01)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
by: Francisco Navarrete, et al.
Published: (2021-05-01)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
by: Luisa Rocha, et al.
Published: (2020-03-01)

Evaluating the effects of gamma-irradiation for decontamination of medicinal cannabis
by: Arno eHazekamp
Published: (2016-04-01)

The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study
by: Darren Reithmeier, et al.
Published: (2018-07-01)

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers
by: Alix Morel, et al.
Published: (2021-02-01)

The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
by: Aleksandra Kicman, et al.
Published: (2020-09-01)

From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
by: Rafael M. Bitencourt, et al.
Published: (2021-02-01)

Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic
by: Lucile Rapin, et al.
Published: (2021-06-01)

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
by: Ila M. Linares, et al.
Published: (2018-10-01)

Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists’ knowledge in Bulgaria
by: Bogdan Kirilov, et al.
Published: (2020-01-01)

The Impact of Cannabidiol on Human Brain Function: A Systematic Review
by: Albert Batalla, et al.
Published: (2021-01-01)

Safety Assessment of a Hemp Extract using Genotoxicity and Oral Repeat-Dose Toxicity Studies in Sprague-Dawley Rats
by: Margitta Dziwenka, et al.
Published: (2020-01-01)

Risk Assessment of Over-the-Counter Cannabinoid-Based Cosmetics: Legal and Regulatory Issues Governing the Safety of Cannabinoid-Based Cosmetics in the UAE
by: Ammar Abdulrahman Jairoun, et al.
Published: (2021-06-01)